bpc-157 and thymosin beta 4 / Beta-4 Nasal Spray Thymosin Beta-4 - Oath Research

Supplementing with the peptide can improve sleep quality

Severe itch in patients with chronic prurigo is associated with the most significant upregulation of CST in the skin

Is hypnotic dose of Trazodone effective for MDD treatment

Subcutaneous planning from a 50 mg vial reconstituted with 3.0 mL BAC water (~16.7 mg/mL) Phase Days 12 (tolerance) Daily dose 2.5 mg once daily Units on U-100 syringe 15 units Volume 0.15 mL Phase Days 3+ (standard) Daily dose 5 mg once daily Units on U-100 syringe 30 units Volume 0.30 mL Phase Split option (BID) Daily dose 2.5 mg twice daily Units on U-100 syringe 15 units each Volume 0.15 mL each Subcutaneous doses are much smaller than oral doses because of injection volume limits and because direct subQ absorption skips the gut